Nuvation Bio Inc. (NUVB)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 25M 50M 75M FY23: 0 FY24: 7.9M FY25: 62.9M FY23 FY24 FY25

Gross Profit Annual

0 300K 600K 900K FY23: 0 FY24: 795K FY23 FY24

Operating Income Annual

-750M -500M -250M 0 250M 500M 750M FY21: -93.3M FY22: -119.7M FY23: -99.8M FY24: -592.6M FY25: -213.1M FY21 FY22 FY23 FY24 FY25

Net Income Annual

-600M -400M -200M 0 200M 400M 600M FY21: -86.8M FY22: -104.2M FY23: -75.8M FY24: -567.9M FY25: -204.6M FY21 FY22 FY23 FY24 FY25

Cost of Revenue Annual

0 300K 600K 900K FY23: 0 FY24: 0 FY25: 856K FY23 FY24 FY25

Operating Cash Flow Annual

-180M -120M -60M 0 60M 120M 180M FY21: -68.2M FY22: -96.1M FY23: -68M FY24: -130.4M FY25: -173.4M FY21 FY22 FY23 FY24 FY25

Free Cash Flow Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Annual

0 150K 300K 450K FY21: 197.9K FY22: 216.7K FY23: 218.9K FY24: 268.8K FY25: 341.5K FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.60 -0.40 -0.20 0.00 0.20 0.40 0.60 Q4 '20: -0.43 Q1 '21: -0.45 Q4 '20 Q1 '21

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.